Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mateusz Piętak
Observed name:
Mateusz Piȩtak
Institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
Observed institutions:
Medical University of Warsaw,
The Maria Sklodowska-Curie National Research Institute of Oncology,
National Medical Institute of the Ministry of Interior and Administration
ORCID:
0000-0001-6451-1238
Observed ORCID:
0000-0001-6451-1238
OpenAlex ID:
A5092315852
Prognostic value of pan-immune-inflammation value and body mass index in geriatric patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first line treatment. A single-center retrospective study
2023
·
Piotr Domański
, Jadwiga Jarosińska
, et al.
·
Współczesna Onkologia
·
10
PDF
How eating sweets affects the skin – the impact of high glycemic index diet on acne formation: A review
2024
·
Barbara Rękas
, Monika Stradczuk
, et al.
·
Journal of Education Health and Sport
·
5
PDF
The influence of air pollution on asthma in athletes – a brief review of the literature
2024
·
Barbara Kruczyk
, Mateusz Piętak
, et al.
·
Quality in Sport
·
4
PDF
Activity of cabozantinib in further line treatment of metastatic clear cell renal cell carcinoma. Real-world experience in a single-center retrospective study
2023
·
Piotr Domański
, Jadwiga Jarosińska
, et al.
·
Współczesna Onkologia
·
4
PDF
Longitudinally extensive transverse myelitis after pembrolizumab and lenvatinib therapy for a rare subtype of renal cell carcinoma: A case report
2025
·
Mateusz Piętak
, Barbara Kruczyk
, et al.
·
Oncology Letters
·
3
PDF
How to treat androgenetic alopecia – the most common form of hair loss. A review
2024
·
Monika Stradczuk
, Łukasz Mazurek
, et al.
·
Journal of Education Health and Sport
·
3
PDF
Analysis of Factors Contributing to Adverse Events and Evaluation of Their Impact on Prognosis in Metastatic Renal Cell Carcinoma Patients—Real-World Experience in a Single-Center Retrospective Study and Narrative Review
2024
·
Piotr Domański
, Mateusz Piętak
, et al.
·
Medicina
·
3
PDF
First experience in treating advanced urothelial cancer with enfortumab vedotin. Single-centre retrospective study of patients qualified for a rescue access procedure
2023
·
Bożena Sikora-Kupis
, Piotr Domański
, et al.
·
Współczesna Onkologia
·
3
PDF
Advancements in the Treatment of Diabetic Macular Edema: Current Strategies and Future Directions
2024
·
Zuzanna Czach
, Magdalena Czach
, et al.
·
Journal of Education Health and Sport
·
2
Adverse Events of Cabozantinib as a Potential Prognostic Factor in Metastatic Renal Cell Carcinoma Patients: Real-World Experience in a Single-Center Retrospective Study
2024
·
Piotr Domański
, Mateusz Piętak
, et al.
·
Biomedicines
·
2
PDF
Salvage chemotherapy in the intensive care unit: a case report of successful treatment of a critically ill patient with metastatic testicular germ cell tumor
2025
·
Karol Grela
, Mykola Sobchynskyi
, et al.
·
Frontiers in Medicine
·
1
PDF
Chronic suppurative otitis media – comorbidities, management and return to sports activities
2024
·
Joanna Olędzka
, Wojciech Kopacz
, et al.
·
Quality in Sport
·
1
The most common contact lens-related complications: A brief review of the literature
2024
·
Wojciech Mazurek
, Barbara Rękas
, et al.
·
Journal of Education Health and Sport
·
1
Dry eye disease as a common ocular disorder – current knowledge and management
2024
·
Barbara Rękas
, Wojciech Mazurek
, et al.
·
Journal of Education Health and Sport
·
1
PDF
Analysis of adverse events associated with VEGFR-TKIs and their impact on prognosis in patients with mRCC — narrative review
2025
·
Piotr Domański
, Szymon Staneta
, et al.
·
Oncology in Clinical Practice
PDF
Details and effects of pre-hospital pharmacotherapy in pediatric population patients with anaphylactic or severe allergic symptoms – a single-center study
2022
·
Mateusz Piętak
, Maksymilian Sroczyński
, et al.
·
Alergologia Polska - Polish Journal of Allergology
PDF
Show more works
View as search
Works count:
16
Citation count:
43
H-index:
4
I10-index:
1
Year
Topic
Type